Xofigo
radium Ra223 dichloride
Prostatic Neoplasms
Date of authorisation:
Revision: 14
Last updated:
MedicineHumanAuthorised
Adakveo
crizanlizumab
Anemia, Sickle Cell
Date of authorisation:
Revision: 6
Last updated:
MedicineHumanRevoked
Adakveo - referral
crizanlizumab
Article 20 procedures
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
EMEA-002141-PIP01-17-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0533/2021
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Concentrate for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Xofigo - referral
radium Ra223 dichloride
Article 20 procedures
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
EMEA-001986-PIP01-16 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0178/2017
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman